Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Russian scientists developed intestinal soluble capsules

Crohn's disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy...

Grindeks invests 800 thousand euros in the creation of a multifunctional site

Joint-stock company “Grindeks” has invested 800 thousand euros in the site of production of active pharmaceutical ingredients (APIs) and installed new, state-of-the-art laboratories and...

The single-component Sputnik Light vaccine authorized in Armenia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by...

EpiVacCorona-N vaccine to be released for use in near future

The EpiVacCorona-N coronavirus vaccine will be released into civil circulation in the near future, Tatiana Nepomnyashchikh, a deputy head of the Vector State Research...

Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination in San Marino

The Russian Direct Investment Fund (RDIF) announces the real world data of the Ministry of Health of San Marino on the Russian Sputnik V...

R-Pharm earned runner-up in BRICS Solutions Awards 2021

R-Pharm`s project on the development of olokizumab has been declared as the Runner-up in the category “Good Health and Well Being” of the BRICS...
spot_img

Expert Articles

spot_img